- GlobeNewswire•5 days agoGalectin Therapeutics to Webcast Corporate Presentation at the MicroCap Conference on October 25 in Philadelphia
NORCROSS, Ga., Oct. 17, 2016-- Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced that Peter G. Traber, M.D., the company's ...
- Accesswire•11 days ago
ARLINGTON, VA / ACCESSWIRE / October 11, 2016 / Galectin Therapeutics, Inc. (NASDAQ:GALT) will be presenting at this year's The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, ...
- GlobeNewswire•15 days agoGalectin Therapeutics to Present Clinical Data on Selective Non-Invasive Tests for the Development of Novel Therapies for Nonalcoholic Steatohepatitis
NORCROSS, Ga., Oct. 07, 2016-- Galectin Therapeutics Inc., the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, today announced it will present two posters ...
Galectin Therapeutics, Inc. (GALT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
|Bid||0.78 x 2000|
|Ask||0.95 x 100|
|Day's Range||0.81 - 0.85|
|52wk Range||0.80 - 3.09|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-0.91|
|Avg Vol (3m)||661,935|
|Dividend & Yield||N/A (N/A)|